Palvella Therapeutics, a clinical-stage biopharmaceutical company, announced the acceptance of an abstract for a poster presentation at the Society for Investigative Dermatology Annual Meeting on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback